Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells? - PubMed (original) (raw)

Review

Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?

H Abken et al. Immunol Today. 1998 Jan.

No abstract available

PubMed Disclaimer

Similar articles

• Targeted cellular immunotherapy with bifunctional antibodies.
  Nelson H. Nelson H. Cancer Cells. 1991 May;3(5):163-72. Cancer Cells. 1991. PMID: 1832553 Review.
• The role of T lymphocytes in the immunotherapy of tumours.
  Brondz BD, Balashov KE. Brondz BD, et al. Biomed Sci. 1991;2(5):441-9. Biomed Sci. 1991. PMID: 1840832 Review.
• Targeted cytotoxic cells as a novel form of cancer immunotherapy.
  Segal DM, Garrido MA, Perez P, Titus JA, Winkler DA, Ring DB, Kaubisch A, Wunderlich JR. Segal DM, et al. Mol Immunol. 1988 Nov;25(11):1099-103. doi: 10.1016/0161-5890(88)90144-7. Mol Immunol. 1988. PMID: 3265476 No abstract available.
• [New era of tumor immunotherapy].
  Yoshitake Y, Nakatsura T, Nishimura Y. Yoshitake Y, et al. Nihon Rinsho. 2005 Apr;63 Suppl 4:46-55. Nihon Rinsho. 2005. PMID: 15861634 Review. Japanese. No abstract available.
• Advances in cancer immunotherapy.
  Ockert D, Schmitz M, Hampl M, Rieber EP. Ockert D, et al. Immunol Today. 1999 Feb;20(2):63-5. doi: 10.1016/s0167-5699(98)01388-7. Immunol Today. 1999. PMID: 10098323 Review. No abstract available.

Cited by

• Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
  Baxevanis CN, Papamichail M. Baxevanis CN, et al. Cancer Immunol Immunother. 2004 Oct;53(10):893-903. doi: 10.1007/s00262-004-0523-y. Epub 2004 May 26. Cancer Immunol Immunother. 2004. PMID: 15168086 Free PMC article. Review.
• Application of atomic force microscope in diagnosis of single cancer cells.
  Lu Z, Wang Z, Li D. Lu Z, et al. Biomicrofluidics. 2020 Sep 4;14(5):051501. doi: 10.1063/5.0021592. eCollection 2020 Sep. Biomicrofluidics. 2020. PMID: 32922587 Free PMC article. Review.
• Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
  Savoldo B, Rooney CM, Di Stasi A, Abken H, Hombach A, Foster AE, Zhang L, Heslop HE, Brenner MK, Dotti G. Savoldo B, et al. Blood. 2007 Oct 1;110(7):2620-30. doi: 10.1182/blood-2006-11-059139. Epub 2007 May 16. Blood. 2007. PMID: 17507664 Free PMC article.
• Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells.
  Gritzapis AD, Mamalaki A, Kretsovali A, Papamatheakis J, Belimezi M, Perez SA, Baxevanis CN, Papamichail M. Gritzapis AD, et al. Br J Cancer. 2003 Apr 22;88(8):1292-300. doi: 10.1038/sj.bjc.6600888. Br J Cancer. 2003. PMID: 12698199 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database